Virilising SertoliLeydig cell tumour associated with thyroid papillary carcinoma: Case report and general considerations

Gynecological Endocrinology

Volumn 26, Issue 8, 2010, Pages 617-622

  Poiana, Catalina ^a   Virtej, Ioana ^b   Carsote, Mara ^a   Banceanu, Gabriel ^a   Sajin, Maria ^a   Stanescu, Bogdan ^a   Ioachim, Dumitru ^a   Hortopan, Dan ^c   Coculescu, Mihail ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Endocrine Private Medical Center   (Greece)

^c C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

Author keywords

amenorrhea; hirsutism; SertoliLeydig cell tumour; testosterone; thyroid carcinoma

Indexed keywords

ANTICOAGULANT AGENT; CHOLESTEROL; CYTOKERATIN; FOLLITROPIN; HEMOGLOBIN; LEVOTHYROXINE; LUTEINIZING HORMONE; PROGESTERONE RECEPTOR; RADIOACTIVE IODINE; TESTOSTERONE;

ADULT; ALOPECIA; ANDROBLASTOMA; ANTICOAGULANT THERAPY; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CARDIOVASCULAR RISK; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; FOLLITROPIN BLOOD LEVEL; GOITER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HIRSUTISM; HISTOPATHOLOGY; HUMAN; HYPERANDROGENISM; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; OVARIECTOMY; OVARY TUMOR; POLYCYTHEMIA; PRIORITY JOURNAL; SECONDARY AMENORRHEA; TESTOSTERONE BLOOD LEVEL; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; ULTRASOUND; VEIN THROMBOSIS; AMENORRHEA; MIDDLE AGED; MULTIPLE CANCER; PAPILLARY CARCINOMA; THYROID TUMOR;

ALOPECIA; AMENORRHEA; CARCINOMA, PAPILLARY; FEMALE; HIRSUTISM; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; SERTOLI-LEYDIG CELL TUMOR; THYROID NEOPLASMS;

EID: 77954782817     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003686361     Document Type: Article

References (29)

1. Meyer R. Pathology of some special ovarian tumors and their relation of sex characteristics. Am J Obstet Gynecol 1931;22: 697.
2. Roth LM, Anderson MC, Govan AD, et al. Sertoli-Leydig cell tumors: a clinicopathologic study of 34 cases. Cancer 1981; 48:187.
3. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors with a retiform pattern: a problem in histopathological diagnosis. A report of 25 cases. Am J Surg Pathol 1983;7:755.
4. Zaloudek C, Norris HJ. Sertoli-Leydig cell tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984;8: 405.
5. Fleckenstein G, Sattler B, Hinney B, et al. Androblastoma of the ovary: clinical, diagnostic and histopathologic features. Onkologie 2001;24:286-291.
6. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasm: A 10-year review. Obstet Gynecol 1989;74:921.
7. Adam S. Levy, Director, Fellowship Training Program, Section of Pediatric Hematology/Oncology, The Children's Hospital at Montefiore, Bronx, NY. Review provided by VeriMed Healthcare Network, Arrhenoblastoma of ovary, Review Date: 5/22/2006.
8. Matzuk MM, Kumar R, Shou W, et al. Transgenic models to study the roles of inhibin and activins in reproduction oncogenesis and development. Recent Prog Horm Res 1996;51:123-157.
9. Fletcher JA, Gibas Z, Donovan K, et al. Ovarian granulosastromal cell tumors are characterized by trisomy 12. Am J Pathol 1991;138:515-520.
10. Villares Fragoso MC, Latronico AC, Marino Carvalho, et al. Activating Mutation of the Stimulatory G Protein (gsp) as a putative cause of ovarian and testicular human Stromal Leydig cell tumors. J Clin Endocrinol Metab 1998;83:2074-2078.
11. Zhao C, Bratthauer G, Barner R, Vang R. Immunohistochemical analysis of Sox9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis. Int J Gynecol Pathol 2007;26:1-9.
12. Talerman A, Hughesdon PE, Anderson M. Diffuse nonlobular ovarian androblastoma usually associated with feminization. Int J Gynecol Pathol 1982;1:155-714.
13. Zung A, Shoham Z, Open M, et al. Sertoli cell tumor causing precocious puberty in a girl with Peutz-Jeghers syndrome. Gynecol Oncol 1998;70:421-424.
14. Koh K, Fukuda Y. Androblastoma in a five-year-old girl. Jpn J Clin Oncol 1989;19:149-152.
15. Poonam S, Raksha A, Chandan D, et al. Sertoli-Leydig cell tumor: a rare ovarian neoplasm. Case report and review of literature. Gynecol Endocrinol 2008;24:230-234.
16. Kasperlik-Zaluska AA, Sikorowa L, Ploch E, et al. Ectopic ACTH syndrome due to bilateral ovarian androblastoma with double, gynandroblastic differentiation in one ovary. Eur J Obstet Gynecol Reprod Biol 1993;52:223-228.
17. Luton JP, Lesobre B, Valcke JC, et al. Precocious pseudopuberty due to HCG-secreting androblastoma of the ovary. One case. Nouv Presse Med 1980;9:2539-2544.
18. Ehrlich EN, Dominguez OV, Samuels LT, et al. Aldosteronism and precocious puberty due to an ovarian androblastoma (Sertoli cell tumor). J Clin Endocrinol Metab 1963;23:358.
19. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985;9:543-569.
20. Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 2005;29:143-156.
21. Sanz OA, Rubio Matinez P, Troyas Guarch R, et al. Bilateral Leydig cell tumor of the ovary: a rare cause of virilization in postmenopausal patient. Maturitas 2007;57:214-216.
22. Roth LM. Recent advances in the pathology and classification of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 2006;25:199-215.
23. Zhao C, Vinh T, McManus K, et al. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 2009;33:354-366.
24. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 2002;26: 1477-1483.
25. Santoro M, Carlomagno F, Hay ID, et al. RET oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992;89:1517-1522.
26. Kimura ET, Nikiforova MN, Zhu Z, et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003;63: 1454-1457.
27. Jensen RD, Norris HJ, Fraumeni JF Jr. Familial arrhenoblastoma and thyroid adenoma. Cancer 1974;33:218-223.
28. O'Brien PK, Wilansky DL. Familial thyroid nodulation and arrhenoblastoma. Am J Clin Pathol 1981;75:578-581.
29. Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology1994;25:549-561.